Cargando...
A Close Look at BACE1 Inhibitors for Alzheimer’s Disease Treatment
Alzheimer’s disease (AD), the most common cause of age-dependent dementia, is one of the most significant healthcare problems worldwide. Aggravating this situation, drugs that are currently US Food and Drug Administration (FDA)-approved for AD treatment do not prevent or delay disease progression. T...
Gardado en:
| Publicado en: | CNS Drugs |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7330928/ https://ncbi.nlm.nih.gov/pubmed/30830576 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40263-019-00613-7 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|